Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>HSBC Research Lifts GALAXY ENT (00027.HK) TP to $43.5, Keeps Rating Buy as LT Growth Prospects to Improve
Recommend 5 Positive 12 Negative 5 |
||||
|
||||
|
Despite a negative impact of $140 million from typhoon Ragasa, GALAXY ENT (00027.HK)'s 3Q25 EBITDA still grew by 5% QoQ on a luck adjusted basis, HSBC Global Research issued a research report saying. Amid fierce competition, its market share remained around 20%. The Group also continued to manage costs, with a reduced mass reinvestment rate from the previous quarter and fixed operating expenses being largely flattish. Management stated that its October results were strong, and the broker expected the Capella Hotel to continue attracting high-end demand, especially with the Group's intensive event arrangements. It is anticipated that the premium positioned phase 4 project will further enhance the Group's long-term growth prospects. HSBC Global Research maintained its earnings forecasts unchanged. However, due to lower-than-expected capital expenditures, the broker lifted its target price from $43 to $43.5, with rating kept at Buy. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
